Agendia, a leader in oncology testing and research, was named to the INC 5000 list for the fastest growing 5000 privately owned companies in America. Agendia checks in at #3,959 on the list. This is an amazing accomplishment for a company that is a leader in breast cancer research. Agendia’s main product lines are named MammaPrint & BluePrint. MammaPrint analyzes an individual’s genetics to determine that person’s risk to develop a form of breast cancer; while BluePrint analyzes the actual tumor itself. Using both product in conjunction can provide patients with a clear path of a treatment plan. Congratulations to Agendia!